English
Back
Open Account
Institutional Q2 Holdings Revealed! What Is "Smart Money" Buying?
牛牛名人追蹤
joined discussion · ·

Tracking Cathie Wood: Added over 200,000 shares of SpaceX, reduced Palantir holdings by over 150,000 shares

The three major US stock indices closed higher collectively on Friday, August 21, 2026. The Dow Jones led the gains, rising 0.98%, while the S&P 500 and Nasdaq each rose 0.43%. Market sentiment was generally optimistic.
Against this backdrop, ARK Invest increased its positions in core disruptive innovation sectors on the day, while rebalancing holdings in AI data infrastructure and certain non-core assets that had seen significant prior gains, achieving a balanced portfolio strategy for both offense and defense.
The three major US stock indices closed higher collectively on Friday, August 21, 2026. The Dow Jones led the gains, rising 0.98%, while the S&P 500 and Nasdaq each rose 0.43%. Market sentiment was generally optimistic. Against this backdrop, ARK Invest increased its positions in core disruptive innovation sectors on the day, while rebalancing holdings in AI data infrastructure and certain non-core assets that had seen significant prior gains, achieving a balanced portfolio strategy for both offense and defense. Buying Direction: Multi-pronged approach, with deep dives into space, gene editing, and blockchain real-world assets $SpaceX (SPCX.US)$ Increased holdings by 205,031 shares, marking the largest buy order of the day. As SpaceX continues to advance the commercialization of Starship and expand global coverage of its Starlink network, its dominant position in low-Earth orbit satellite communications and space transport may lead ARK to view it as a core infrastructure asset for the next decade, prompting continued increased exposure. $Intellia Therapeutics (NTLA.US)$ Increased holdings by 115,499 shares. Intellia is a leader in in vivo gene editing that ARK has long favored. Its CRISPR therapy pipeline continues to accumulate clinical data. If it can successfully tackle more genetic diseases in the future, there is significant room for valuation reassessment, aligning with ARK's long-term investment logic in precision medicine. $Securitize (SECZ.US)$ Increased holdings by 85,393 shares. As...
Symbols
--
--
--
Buying Direction: Multi-pronged approach, with deep dives into space, gene editing, and blockchain real-world assets
$SpaceX (SPCX.US)$ Increased holdings by 205,031 shares, marking the largest buy order of the day. As SpaceX continues to advance the commercialization of Starship and expand global coverage of its Starlink network, its dominant position in low-Earth orbit satellite communications and space transport may lead ARK to view it as a core infrastructure asset for the next decade, prompting continued increased exposure.
$Intellia Therapeutics (NTLA.US)$ Increased holdings by 115,499 shares. Intellia is a leader in in vivo gene editing that ARK has long favored. Its CRISPR therapy pipeline continues to accumulate clinical data. If it can successfully tackle more genetic diseases in the future, there is significant room for valuation reassessment, aligning with ARK's long-term investment logic in precision medicine.
$Securitize (SECZ.US)$ Increased holdings by 85,393 shares. As a representative platform in the Real-World Asset (RWA) tokenization sector, Securitize bridges traditional finance and on-chain assets. This move by ARK may reflect its continued bet on the long-term thesis that blockchain will reshape capital market infrastructure.
$BWX Technologies (BWXT.US)$ Increased holdings by 69,979 shares. BWXT specializes in nuclear energy technology, particularly small modular reactors (SMRs) and military nuclear power. Against the backdrop of rapidly rising energy demand driven by AI computing power, ARK's increased stake may represent a strategic allocation to the foundational supply side of clean energy.
$Freenome (FRNM.US)$ Increased holdings by 16,003 shares. Freenome focuses on AI-driven early cancer detection via liquid biopsy, fitting ARK's core narrative that 'multi-gene testing will disrupt traditional cancer screening.' It may be viewed as an important addition to the precision medicine portfolio.
Increased holdings in the 3iQ Solana Staking ETF (SOLQ.U.US) by 5,844 shares. ARK continues to increase its exposure to Solana, likely bullish on the application potential of Solana's high-throughput public chain in DeFi and real-world asset tokenization scenarios. Participating via an ETF also helps mitigate the volatility risk associated with direct token holdings.
Selling Strategy: Phased adjustments to high-valuation AI targets and non-core positions.
$Palantir (PLTR.US)$ Reduced holdings by 156,110 shares, marking the largest sell-off of the day. Palantir's stock price has recently been driven by expectations of AI government contracts, pushing valuations to high levels. This reduction by ARK may reflect active management of position concentration, reallocating capital to disruptive innovation targets with more attractive valuations.
$Roblox (RBLX.US)$ Reduced holdings by 26,616 shares. Roblox is still exploring its commercialization path in the metaverse and user-generated content (UGC) sectors. ARK's adjustment may indicate a reassessment of the balance between its short-term fundamental progress and valuation, moderately reducing the position to manage volatility.
$10x Genomics (TXG.US)$ Reduced holdings by 10,033 shares. 10x Genomics holds a unique competitive advantage in the field of spatial genomics. ARK's reduction of 10,033 shares is likely a routine portfolio rebalancing operation rather than a negation of its long-term investment thesis, and the overall position may still maintain a certain proportion.
$Brera Holdings (SLMT.US)$ Reduced holdings by 6,736 shares. Brera Holdings is a relatively small-cap holding within ARK's portfolio. The limited scale of this reduction suggests it is part of regular portfolio review and dynamic optimization.
$Shopify (SHOP.US)$ Reduced holdings by 4,884 shares. As a key player in e-commerce infrastructure, Shopify saw a modest reduction of 4,884 shares by ARK. This may reflect capital rebalancing needs or a reassessment of opportunity costs relative to core AI sectors.
$Deere (DE.US)$ Reduced holdings by 3,935 shares. As a representative stock in precision agriculture and agricultural automation, Deere experienced a slight reduction of 3,935 shares. This may indicate ARK is fine-tuning its agtech exposure to concentrate more capital on high-growth core sectors such as AI and biotechnology.
Futubull [Opportunity Page] has launched tracking for celebrity portfolio opportunities! Choose from multiple celebrity holdings, follow big investors' layouts with one click, precisely lock in high-quality targets, and invest with greater confidence!
The three major US stock indices closed higher collectively on Friday, August 21, 2026. The Dow Jones led the gains, rising 0.98%, while the S&P 500 and Nasdaq each rose 0.43%. Market sentiment was generally optimistic. Against this backdrop, ARK Invest increased its positions in core disruptive innovation sectors on the day, while rebalancing holdings in AI data infrastructure and certain non-core assets that had seen significant prior gains, achieving a balanced portfolio strategy for both offense and defense. Buying Direction: Multi-pronged approach, with deep dives into space, gene editing, and blockchain real-world assets $SpaceX (SPCX.US)$ Increased holdings by 205,031 shares, marking the largest buy order of the day. As SpaceX continues to advance the commercialization of Starship and expand global coverage of its Starlink network, its dominant position in low-Earth orbit satellite communications and space transport may lead ARK to view it as a core infrastructure asset for the next decade, prompting continued increased exposure. $Intellia Therapeutics (NTLA.US)$ Increased holdings by 115,499 shares. Intellia is a leader in in vivo gene editing that ARK has long favored. Its CRISPR therapy pipeline continues to accumulate clinical data. If it can successfully tackle more genetic diseases in the future, there is significant room for valuation reassessment, aligning with ARK's long-term investment logic in precision medicine. $Securitize (SECZ.US)$ Increased holdings by 85,393 shares. As...
Risk Disclaimer: The above content only represents the author's view. It does not represent any position or investment advice of Futu. Futu makes no representation or warranty.Read more
Thumbs Up
15
Emm
1
Lol
1
362K Views
Report
Comments (10)
Write a Comment...
10
17
21